Harvard and Roche Develop Foundation AI Model to Predict and Explain Immunotherapy Response Across 33 Cancer Types

Researchers from Harvard Medical School and Roche have developed COMPASS, a foundation AI model designed to predict patient response to …

Continue ›››

Haya Therapeutics Raises $65M to Develop RNA Drugs Targeting the Dark Genome

Haya Therapeutics has raised $65 million in Series A financing to support development of therapies targeting long non-coding RNAs (lncRNAs), …

Continue ›››

Persist AI Launches Robotic Cloud Lab for Formulation Development, Raises $12M Series A

Persist AI, a startup focused on accelerating pharmaceutical formulation development through AI-guided robotics, has launched its Cloud Lab platform and …

Continue ›››

Pusan National University Researchers Develop AI Model to Identify Therapeutic Gene Targets Using Hypergraphs

A team from Pusan National University, led by Associate Professor Giltae Song, has developed a new artificial intelligence model called …

Continue ›››

Lokavant Releases AI-Based Forecasting Tool for Clinical Trial Enrollment

Lokavant has launched Spectrum v15, an AI-powered clinical trial forecasting platform designed to reduce uncertainty in feasibility planning and enrollment …

Continue ›››

BlackfinBio Receives FDA Clearance to Begin Clinical Trial for Gene Therapy in Rare Childhood Motor Disorder

BlackfinBio, a UK-based gene therapy company, has received FDA clearance to begin a Phase 1/2 trial of its AAV-based candidate …

Continue ›››

Real-World Study Reports 91% of Tinnitus Patients Improved With Neuromod's FDA-Approved Device

A real-world study published in Nature Communications Medicine has reported that 91.5 percent of tinnitus patients experienced a clinically meaningful …

Continue ›››

NeoGenomics Adopts Ultima Genomics Platform to Expand Sequencing-Based Oncology Diagnostics

NeoGenomics has partnered with Ultima Genomics to integrate the UG 100 sequencing platform into its Cambridge, UK innovation center, aiming …

Continue ›››

Molecular Devices Launches Automated System for Microbial Colony Picking

Molecular Devices has introduced the QPix FLEX Microbial Colony Picking System, a compact, automated platform for microbial colony screening. The …

Continue ›››

Atropos Health Adds Ontada Oncology Data to Expand Community Cancer Coverage in Real-World Evidence Network

Atropos Health has integrated data from Ontada, a McKesson company focused on community oncology, into the Atropos Evidence Network. The …

Continue ›››

Deep Genomics Releases AI Foundation Model for microRNA Binding and mRNA Degradation Prediction

Deep Genomics has introduced REPRESS, a deep learning model trained to predict microRNA (miRNA) binding and mRNA degradation directly from …

Continue ›››

Datavant to Acquire Aetion, Expanding Into End-to-End Real-World Evidence Analytics for Life Sciences

Datavant has announced its acquisition of Aetion, a real-world evidence (RWE) platform used by regulators and biopharma companies to assess …

Continue ›››